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Available online 20 April 2016The identiﬁcation of pathways necessary for retinal pigment epithelium (RPE) function is fundamental to uncov-
er therapies for blindness. Prolactin (PRL) receptors are expressed in the retina, but nothing is known about the
role of PRL in RPE. Using the adult RPE 19 (ARPE-19) human cell line andmouse RPE, we identiﬁed the presence
of PRL receptors and demonstrated that PRL is necessary for RPE cell survival via anti-apoptotic and antioxidant
actions. PRL promotes the antioxidant capacity of ARPE-19 cells by reducing glutathione. It also blocks the hydro-
gen peroxide-induced increase in deacetylase sirtuin 2 (SIRT2) expression, which inhibits the TRPM2-mediated
intracellular Ca2+ rise associated with reduced survival under oxidant conditions. RPE from PRL receptor-null
(prlr−/−) mice showed increased levels of oxidative stress, Sirt2 expression and apoptosis, effects that were ex-
acerbated in animals with advancing age. These observations identify PRL as a regulator of RPE homeostasis.
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Retinal pigment epithelium1. Introduction
As aging populations grow, sight loss is becoming a major world
health concern. Eye conditions related to aging share some common
pathological characteristics, including the degeneration of the retinal
pigment epithelium (RPE) (Ambati et al., 2003) and secondary photore-
ceptor cell damage (Organisciak and Vaughan, 2010). Several lines of
evidence have determined oxidative stress in the RPE to be a major
pathogenic element in age-related macular degeneration (AMD)
(Shen et al., 2007) and diabetic retinopathy (Du et al., 2013). Oxidative
stress refers to elevated intracellular levels of reactive oxygen species
(ROS) (Cross et al., 1987), which are produced by damaged mitochon-
dria and which inevitably impair cellular function (Balaban et al.,
2005). Recently, oxidative stress was shown to induce an age-
dependent increase in ROS levels and cell death in human RPE (He
et al., 2014). However, the molecular mechanisms making aging RPE
vulnerable to high levels of ROS and subsequent activation of cell
death are largely unknown.niversidad Nacional Autónoma
rétaro, Qro., Mexico.
bault).
. This is an open access article underWe have recently identiﬁed the neuroprotective role of prolactin
(PRL) in rat retinas (Arnold et al., 2014). PRL is a critical link between
the neuroendocrine and immune systems. Notably, deep sequencing
experiments showed that increased vulnerability to AMD is due to ini-
tially high levels of inﬂammatory factors and low levels of homeostatic
neuroprotective factors, such as the suppressor of cytokine signaling
(SOCS) 1 (Mustaﬁ et al., 2012; Swaroop et al., 2009). PRL signaling is
down-regulated when SOCS-1 is lost (Minoo et al., 2004). Together,
these ﬁndings indicate that PRL signaling may play a critical role in the
age-related degeneration of the retina.
PRL and its receptor are expressed in the retina (Rivera et al., 2008).
Retinas from PRL receptor knockout (prlr−/−) mice exhibit photo-
responsive dysfunction that correlates with reduced rhodopsin levels
(Arnold et al., 2014). Given that the RPE normally supplies
photopigments to rods (Nandrot et al., 2008), a lack of PRL signaling
may alter its function. A previous study demonstrated that most retinal
cells are positive for the PRL receptor (Rivera et al., 2008), but whether
this receptor is present in the RPE remains to be determined.
In addition, there is abundant evidence of altered Ca2+ dynamics in
cells with increased age (Toescu et al., 2004) and oxidative stress
(Camandola and Mattson, 2011), which are partially mediated by tran-
sient receptor potential (TRP) channel dysfunction (Pena and Ordaz,
2008). Notably, TRP melastatin 2 (TRPM2) is a unique Ca2+-permeable,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Penner, 2014) and that has been implicated in cell death in response
to oxidative stress (Takahashi et al., 2011). Emerging evidence supports
the idea that glutathione (GSH) depletion, which occurs during aging
(Rebrin et al., 2007), associateswith altered intracellular Ca2+dynamics
that may develop in neurons as a result of increased TRPM2-mediated
Ca2+ inﬂux (Ovey and Naziroglu, 2015). Reinforcing the possibility
that TRPM2 may contribute to neurological diseases associated with
aging and oxidative stress is the fact that this channel is gated by the
sirtuin metabolite 2′O-acetyl-ADP-ribose (Grubisha et al., 2006; Tong
and Denu, 2010). Sirtuins are a conserved family of protein/histone
deacetylases, of which the founding member Silencing Information
Regulator 2 (SIRT2) has been suggested to be neuroprotective when
inhibited (Hall et al., 2013). Indeed, reduced sirt2 expression associates
with increased photoreceptor survival in ﬂies (Pallos et al., 2008),
although it is not yet clearwhether SIRT2 activation has negative effects
in aging retinas.
Here we demonstrate that PRL is necessary for the survival of RPE
under normal and advancing age conditions. We further identiﬁed
SIRT2 and TRPM2 as molecular targets for the antioxidant and anti-
apoptotic actions of PRL in the RPE.
2. Materials and Methods
2.1. Reagents
Human recombinant PRL (Freeman et al., 2000) generated in
Escherichia coli was provided by Michael E. Hodson (Yale University,
New Haven, CT). The PRL receptor antagonist Del1-9-G129R-hPRL was
produced in Escherichia coli and puriﬁed as described (Bernichtein
et al., 2003). Anti-human PRL rabbit polyclonal antibody IC5 and anti-
TRPM2 (#ACC-043) were kind gifts from the National Hormone and Pi-
tuitary Program (UCLA Medical School, Torrance, CA) and Alomone
Labs, respectively. Normal rabbit serum was collected from control
(non-immunized) rabbit whole blood. N-acetyl cysteine (Cat. number
A7250) (Mennicke et al., 1987), AGK2 (Cat. number A8231) (Villalba
and Alcain, 2012), and piceatannol (Cat. Number P0453) (Gill et al.,
1987) were purchased from Sigma-Aldrich (St. Louis, MO). Anti-PRL
receptor (U5, Novus Biologicals, Littleton, CO), Alexa-488 goat anti-
mouse IgG (ab150117, Abcam, Carlsbad, CA), anti-RPE65 (MAB5528,
Chemicon International, Temecula, CA) and anti-β-tubulin (ZYMED
from Life Technologies; #22833) antibodies were purchased as
speciﬁed.
2.2. Ethics Statement
All experiments were approved by the Bioethics Committee of the
Institute of Neurobiology from the National Autonomous University of
Mexico (UNAM, clave NOM-062-ZOO-1999) in accordance with the
rules and regulations of the Society for Neuroscience: Policies on the
Use of Animals and Humans in Neuroscience Research. All efforts were
made to minimize the number of animals used and their suffering.
2.3. Animal Care and Retinal Tissue
Male albino rats (Wistar, 275 ± 25 g, 7–9 weeks) and 30 male and
30 female albino mice (129Sv, 33 ± 2 g, 3 month old) were fed ad
libitum and reared in normal cyclic light conditions (12 h light: 12 h
dark) with an ambient light level of approximately 400 lx. Animals
were sacriﬁced by CO2 inhalation and decapitation. Eyes were enucleat-
ed and processed for in situ hybridization and immunohistochemistry.
2.4. Mice
Mice heterozygous for PRL receptor ((Ormandy et al., 1997); 129Sv
background) were crossbred, and PRL receptor-null (prlr−/−) micewere selected as previously described (Arnold et al., 2014). Wild-type
(16 males and 13 females) and prlr−/− (14 males and 17 females)
mice were subjected to normal cyclic light until they reach 5 or
14 months of age. After a 24-h dark adaptation period, mice were killed
by CO2 inhalation and decapitation. Eyes were enucleated, and ﬂat
mounts of RPE were obtained (Claybon and Bishop, 2011) and proc-
essed for histology, apoptosis, and immunostaining, or retinas were ob-
tained for RNA extraction.2.5. In Situ Hybridization
Sense and antisense PRL receptor RNA probes labeled with
digoxygenin were synthesized from a linearized plasmid containing
the rat PRL receptor cDNA. Isolated retinas were ﬁxed for 24 h in 4%
formaldehyde, incubated for 24 h in RNase-free 10% sucrose-
phosphate buffered saline (PBS), then for 3 days in 30% sucrose-
PBS. Retinas were embedded in Tissue-Freezing Medium (Leica
Instruments, Neussloch, Germany), sectioned (12 μm), and mounted
on slides (Superfrost/Plus; A. Daigger & Co., Vernon Hills, IL). Sec-
tions were dried for 15 min at 60 °C, ﬁxed with 4% formaldehyde
for 10 to 15 min in PBS, and washed in PBT (PBS + 0.1% Tween 20).
Sections were incubated in a 1:1 mixture of PBT and hybridization
solution (5× sodium chloride and sodium citrate solution), 0.1%
Tween 20, 50% deionized formamide, 100 μg/ml sonicated salmon
sperm DNA) and prehybridized in hybridization solution for 1 h at
55 °C. Probes were denatured in hybridization solution and allowed
to hybridize to tissue sections overnight at 55 °C. Slides were washed
at 60 °C with hybridization solution and then with PBT. They were
incubated for 2 h with an anti-digoxygenin antibody coupled to alka-
line phosphatase (Roche, Basel, Switzerland), then washed in PBT.
Signal was detected using tetrazolium blue and 5-bromo-4-chloro-
3-indolyl phosphate as substrates in alkaline buffer (Roche).2.6. Immunohistochemistry
Eyes were ﬁxed in 4% paraformaldehyde. Then, they were either
washed overnight in 0.1 M PBS, immersed in 15% sucrose at room tem-
perature, oriented and frozen in Tissue-Tek (Sakura Finetek, Torrance,
CA), and sectioned (12 μmthick) along the sagittal axis of the eye or dis-
sected for a whole mount of the RPE as described (Claybon and Bishop,
2011). Retina cryosections and RPE ﬂat mounts were incubated in PBS
with 1% SDS for 5 min, rinsed three times with PBS for 5 min, blocked
in PBS containing 10% normal goat serum and 0.1% Triton X-100 for
1 h, and then incubated overnight at 4 °C with anti-PRL receptor mono-
clonal antibody (U5) at 20 μg/ml. The primary antibody reaction was
detected using the avidin-biotin complex-detection kit (Vectastain,
ABC kit; Vector Laboratories, Burlingame, CA) or labeled with Alexa-
488 goat anti-mouse IgG used at 1:200 dilution. RPE ﬂat mounts were
then incubated with a 1:1000 dilution of rhodamine phalloidin (R415,
Thermo Fisher Scientiﬁc, Waltham, MA) for 1 h. Double labeling was
performed with both anti-PRL and anti-RPE cell speciﬁc antibodies
[anti-PRL polyclonal antibody IC5, dilution 1:500; anti-RPE65, at
0.08 μg/ml]. After incubation with the primary antibodies, samples
were rinsed 3 times in PBS and labeled for 2 hwith Alexa-594-conjugat-
ed goat anti-mouse IgG, or Alexa-488-goat anti-rabbit IgG obtained
from Molecular Probes (Eugene, OR) and used at dilutions of 1:500
(anti-mouse) or 1:1000 (anti-rabbit), respectively. Control for the U5
anti-PRL receptor antibody was carried out using prlr−/− mice
(Fig. 1b), and secondary antibody control for the IC5 anti-PRL antibody
was carried out omitting the primary antibody (data not shown). La-
beled samples were examined with a laser scanning confocal micro-
scope (Zeiss Axiovert 200 LSM 510 Meta, Carl Zeiss International,
Oberkochen, Germany). Images were prepared using the Zeiss LSM
Image Examiner.
Fig. 1. PRL receptor and PRL expression in the RPE. (a) Representative image of in situ hybridization of transverse sections from rat eyes showedmarked expression of the PRL receptor in
the RPE, the outer limiting membrane (OLM), the outer (ONL) and inner (INL) nuclear layers, and ganglion cell layer (GCL) with the antisense probe (left panel). No speciﬁc staining was
observedwith the sense probe (right panel). Arrows indicate RPE. (b) Representative confocal stack image of RPEwholemounts fromwild-type (prlr+/+) and PRL receptor-null (prlr−/−)
mice showing PRL receptor (green) and F-actin (stained by phalloidin, red) immunoﬂuorescence in x-y axis and z-axis projection (0.5 μmstep size). No speciﬁc signal against PRL receptor
was observed in prlr−/− RPE cells. Corresponding separate x-y axis images were included in Supplemental Fig. 2. (c) Representative confocal images of transverse sections of rat retinas
showing RPE-65 (red) and PRL (green) immunoﬂuorescence. PRL was present in choroid and retinal cell layers. Co-labeling of RPE and PRL showed strong immunostaining in the
cytoplasm of RPE cells (yellow, right panel). Magniﬁcation bars were as indicated. In experiments of each panel, images were captured in three different regions of the same retina
section (n = 3). Both retinas of four animals (per group in b) were analyzed (N = 6). Two male and two female from each genotype (prlr+/+ and prlr−/−) were analyzed in b.
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RPE ﬂat mounts were ﬁxed in 4% paraformaldehyde (PFA) and
permeabilized with 0.1% Triton X-100 and 0.1% sodium citrate for
7 min followed by incubation in sodium citrate buffer (10 mM sodium
citrate, 0.5% Tween 20, pH 6.0) for 1min at 86 °C. Apoptosis was detect-
ed by the terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL)method using the In Situ Cell Death Detection Kit (Roche Diag-
nostics). DNA was stained with DAPI (4′,6-diamidino-2-phenylindole
(Stohr et al., 1977), 1 μg/ml, Sigma-Aldrich). Apoptotic signals were vi-
sualized under ﬂuorescence microscopy (Microscope BX60F5, Olympus
Optical Co. LTD) and quantiﬁed by the image analysis system software
Pro-Plus (Media Cybernetics Inc.).2.8. Detection of Intracellular ROS
The in situ production of ROS in the RPE was assessed using
dihydroethidium (DHE, structure is provided in Supplemental
Fig. 1a) staining. RPE ﬂat mounts were ﬁxed in 4% PFA and mounted
on gelatin-coated slides. In a dark chamber, RPE was loaded with
5 μM DHE for 30 min at room temperature and then washed thrice
in PBS. RPE was mounted on glass slides with VECTASHIELD®
mounting medium with DAPI, and the slides were analyzed without
delay using a LSM 510 confocal laser-scanning microscope. Images
were obtained using an Apo-406 objective. The same acquisition set-
tings were used for all experiments to allow direct comparison of
RPE ﬂat mounts. Digital images were processed using free ImageJ
software (V.1.36, National Institutes of Health). Only cropping of im-
ages was performed; there was no adjustment of brightness. The
mean ﬂuorescence intensity ratio in RPE was determined in 6 differ-
ent regions of interest (same size), distributed equally over the full
layer, from three ﬂat mounts per condition. The ratio between DHE(numerator) and DAPI was calculated to determine superoxide
anion production in the three experimental groups.
2.9. Cell Culture
The ARPE-19 human cell line was purchased from ATCC (Number:
CRL-2302) (Dunn et al., 1996) and was grown in Dulbecco's Modiﬁed
Eagle's Medium nutrient mixture F12 supplemented with 10% fetal bo-
vine serum and 1% penicillin/streptomycin. Cultures were seeded at an
initial density of 106 cells and maintained at 37 °C and 5% CO2. Because
serum contains variablemixtures of factors that mightmodulate the ef-
fects of PRL, we preincubated the cultures in serum-reduced (1%)medi-
um for 12 h prior treatments.
2.10. RNA Isolation and cDNA Synthesis
Retinas were dissected for mRNA analysis. Total RNA from retinas
and ARPE-19 cells was isolated using TRIzol reagent (Invitrogen,
Waltham, MA). Total RNA was quantiﬁed. For retina RNA, contaminat-
ing genomic DNA was removed using 1 ml of RNase-free DNase I
(BoehringerMannheim)/10 mg of RNA at 37 °C for 30 min. A 1-mg
sample (retinas) and a 2-μg sample (ARPE-19 cells) were reverse-
transcribed using the High-Capacity cDNA Reverse Transcription Kit
(Life Technologies, Carlsbad, CA).
2.11. Conventional PCR
For the PCR reaction, speciﬁc sense and antisense primers were se-
lected (Table 1), based on GenBank TRP sequences, using GeneJockey
II (Biosoft, Cambridge, UK). Each sample was ampliﬁed using Maxima
SYBR Green/ROX qPCR Master Mix (Thermo Scientiﬁc, Auburn, AL) in
an automated thermal cycler (Bio-Rad CFX96 Real-Time System; Bio-
Rad Laboratories, Hercules, CA). DNA ampliﬁcation conditions included
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AmpliTaq Gold) and 40 cycles of 30 s at 95 °C; 30 s at 57 °C for the
PRL receptor, 60 °C for TRPM2, and 57 °C for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH); 40 s at 72 °C, and a ﬁnal elongation of
7min at 72 °C. The RT-PCR sampleswere electrophoresed on a 1.5% aga-
rose gel and stained with ethidium bromide (0.5 μg/ml), then
photographed under UV light.2.12. Quantitative PCR
PCR products were detected and quantiﬁed with Maxima SYBR
Green qPCR Master Mix (Thermo Scientiﬁc) in a 10-μl ﬁnal reaction
volume containing template and 0.5 μM of each of the primer pairs
(Table 2). Ampliﬁcation performed in the CFX96 real-time PCR detec-
tion system (Bio-Rad, Hercules, CA) included a denaturation step of
10 min at 95 °C, followed by 40 cycles of ampliﬁcation (10 s at 95 °C,
30 s at the primer pair–speciﬁc annealing temperature, and 30 s at
72 °C). The PCR data were analyzed by the 2–ΔΔCT method, and cycle
thresholds normalized to the housekeeping gene TBP were used to
calculate the mRNA levels of interest.2.13. Transient Transfection
ARPE-19 cells were transfected with 50 nM siRNA against human
TRPM2 (SMARTpool: SiGENOME TRPM2 siRNA, NCBI substance Id
152147430, GE Dharmacon, Lafayette, CO) using Lipofectamine 2000
(Invitrogen). Control experiments were performed by transfecting the
SiGENOME non-targeting control siRNAs, Cat# D-001210-01-05, GE
Dharmacon) or by exposing cells to Lipofectamine 2000 without
siRNA. Analysis of protein content, Ca2+ imaging and survival assays
were performed 24 h after transfection.2.14. Immunocytochemistry
ARPE-19 cell cultures were ﬁxed in 4% PFA for 1 h, incubated in PBS
with 1% SDS for 5min, rinsed three times with PBS for 5min, blocked in
PBS containing 10% normal goat serum and 0.1% Triton X-100 for 1 h,
and then labeled overnight at 4 °C with anti-PRL receptor monoclonal
antibody (U5) at 20 μg/ml. The primary antibody was detected with
Alexa-488 goat anti-mouse IgG (ab150117) used at 1:200 dilution. F-
actin was stained with a 1:1000 dilution of rhodamine-phalloidin
(R415, Thermo Fisher Scientiﬁc, Waltham, MA, structure is provided in
Supplemental Fig. 1b) for 1 h. Samples were then mounted on glass
slides with VECTASHIELD®mountingmediumwith DAPI. Labeled sam-
ples were examined with a laser scanning confocal microscope (Zeiss
Axiovert 200 LSM 510 Meta). Images were prepared using the Zeiss
LSM Image Examiner.2.15. Immunoblotting
Conditioned media from 3-day conﬂuent ARPE-19 cell cultures
were collected and concentrated 30-fold using Amicon® Ultra cen-
trifugal ﬁlters (Merck Millipore, Darmstadt, Germany). In another
group of experiments, ARPE-19 cells were transfected with siRNA
against human TRPM2 or control siRNA for 48 h. Protein samples
were resuspended in lysis buffer (0.5% Igepal, 0.1% SDS, 50 mM
Tris, 150 mM NaCl, 1 μg/ml aprotinin, and 100 μg/ml PMSF, pH 7.0),
and subjected to SDS/PAGE; total protein (40 μg) was blotted and
probed overnight with a 1:500 dilution of anti-PRL IC5 antibody, a
1:200 dilution of anti-TRPM2 or a 1:1000 dilution of anti-β-tubulin
antibodies. Primary antibody detection was performed using an al-
kaline phosphatase-coupled secondary antibody and a colorimetric
detection kit (Bio-Rad).2.16. Viability Assay
The reduction of 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoli-
um bromide (MTT) was used as an index of RPE cell survival. Cells were
seeded in 96-well collagen-coated ﬂat bottom microculture plates
(Corning) at an initial density of 2500 cells/well and treated for 48 h
with 1% FBS culture medium supplemented or not (control) with
100 pM PRL, anti-human PRL antibody (dilution 1:500; deﬁned in
pilot experiments), normal serum control, Del1-9-G129R-hPRL (0.1
and 1 μM; deﬁned in pilot experiments), or increasing doses of H2O2,
as indicated. In another group of experiments, ARPE-19 cells were incu-
bated with 100 μM H2O2 in the presence or absence of 100 pM PRL,
10 μM antioxidant N-acetyl cysteine, 10 μM SIRT2 inhibitor AGK2 or
siRNA against TRPM2, as indicated. Piceatannol (10 μM)was also tested.
The dose of hPRL (100 pM) that maximally promoted ARPE-19 cell sur-
vival was determined by performing a dose-response assay (not
shown). Based on PRL levels detected in 10% FBS medium (Fig. 2e), we
calculated that 1% FBS medium contains a few pg/ml of PRL, which
may be considered negligible compared to the concentrations present
in the conditioned medium of ARPE-19 cells (1.7 ± 2.1 ng/ml, Fig. 2e)
and the 100 pM (i.e. 2.3 ng/ml) exogenously administered PRL. Next,
cells were incubated with MTT (500 mg/ml, Sigma-Aldrich) at 37 °C
for 3 h, and the formazan precipitatewas solubilizedwith 0.4NHCl con-
taining 10% SDS for 30min at room temperature and quantiﬁed bymea-
suring absorbance at 570 nm.
2.17. Cell Proliferation Assay
Cell proliferation was assessed by [3H]thymidine incorporation
(Amersham International plc, Cardiff, UK). The [3H]thymidine incorpo-
ration assay consisted in seeding cells in 48-well collagen-coated ﬂat-
bottom microculture plates (Corning) at an initial density of 5000
cells/well and subjecting them to a series of treatments (all in 200 μl
of culture medium containing 1% FBS) that included a 24-h incubation
with recombinant human PRL (100 pM) combined or not with Del1-
9-G129R-hPRL (1 μM), or with H2O2 (100 μM). Twenty-four hours be-
fore ending the treatment, 1 μL of [3H]-thymidine per well was added.
After the 48-h treatment, wells werewashed thrice in 5% trichloroacetic
acid, with the last wash for 20 min at 4 °C. Next, 250 μL boiling 0.25 N
NaOH was added, and samples were transferred to scintillation vials
for quantiﬁcation.
2.18. Apoptosis Detection
ARPE-19 cells were assayed for apoptosis by measuring fragmented
nucleosomal DNA using the Cell Death Detection ELISA Kit (Roche).
2.19. Measurement of Total ROS and Antioxidant Capacity Using the Victor3
V Microplate Reader
Total ROS levels (The Enzo Life Sciences' Total ROS/Superoxide de-
tection kit; ENZ-51010) and antioxidant capacity (Cayman Chemical,
Ann Arbor, MI; 709001) were assessed according to the Manufacturer's
instructions.
2.20. Quantiﬁcation of GSH Levels
GSH levels in lysates from ARPE-19 cells were measured with the
GSH-glo-glutathione-assay (Promega) according to the Manufacturer's
instructions. GSH concentrations were determined by interpolation
from a GSH standard curve generated using the bioluminescent system.
2.21. Ca2+ Imaging
For Ca2+ imaging studies, ARPE-19 cells at conﬂuence were plated
onto round coverslips covered with poly-L-lysine (10 μg/ml, Sigma
Fig. 2. Endogenous PRL is a trophic factor for RPE cells. (a) RT-PCR of PRL receptor (PRLR, 200 bp) in ARPE-19 cell extracts. GAPDHwas used as a positive control. bp, DNA ladder. RT-PCR
was performed in RNA extracted from three independent cell cultures (N= 3). (b) Confocal stack image of ARPE-19 cells showing F-actin (red), nucleus (blue), and PRL receptor (green)
immunoﬂuorescence in x-y axis. Corresponding x-y axis images and z-axis projection were included in Supplemental Fig. 3a and b, respectively. PRL receptor was present in a non-
uniform, punctuate distribution along the ARPE-19 cell border (left panel). The secondary antibody control was carried out by omitting the anti-PRL receptor antibody (right panel).
Images were captured in three different regions of the culture plate (n = 3), three independent cultures were analyzed (N = 3). (c) Western blot analysis of PRL in conditioned media
(CM) from 3-day ARPE-19 cells. A standard of 23-kDa PRL (Std) was included, and equal concentrations of total proteins were loaded. Also, a series of standard PRL dilutions was
included at indicated concentrations. CM from ﬁve 3-day ARPE-19 cell cultures concentrated by a ~2-fold factor was analyzed and this same experiment was repeated three times
(N = 3). (d) Quantiﬁcation of PRL in the CM of 3-day ARPE-19 cells by the Nb2-bioassay. 10% FBS medium was included. Note that CM was not concentrated. Three samples from CM
from ﬁve 3-day ARPE-19 cell cultures were analyzed and this same experiment was repeated three times (N = 3). (e) Effect on survival of ARPE-19 cells treated with 10% FBS,
polyclonal α-PRL antibody (α-PRL Ab) or preimmune serum (ctl Ab), pure PRL receptor antagonist Del1-9-G129R-hPRL at 0.1 and 1 μM or untreated (ctl) for 48 h was measured by
MTT assay (n = 8; N = 3 independent experiments). BLK, averaged blank. (f) ARPE-19 proliferation after treatment with 100 pM hPRL, 1 μM Del1-9-G129R-hPRL or no treatment was
measured by incorporation of [3H]thymidine for 24 h after the treatments. Scintillation signals were normalized to the untreated condition (n = 9; N = 3 independent replicates). All
bar plots, mean plus S.E.M.; P values: ANOVA and Bonferroni post-hoc test. Of note, the control condition corresponds to cells that were pre-treated with 1% FBS medium during 12 h
followed by a 48-h period in the same medium.
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dissolved in the extracellular buffer containing: 150 mM NaCl, 20 mM
HEPES, 0.1 mg/ml bovine serum albumin, 1.0 mM EGTA, adjusted to
pH 7.4withNaOH. Loaded cells were transferred into a perfusion cham-
ber located on a microscope adapted to an epiﬂuorescence system(Eclipse E600FN; Nikon Melville, NY). Cells were constantly perfused
with oxygenated extracellular buffer at a rate of 15–17 ml/min and at
29–30 °C. Excitation of the ﬂuorophore (at 488 nm) was performed
with a light source controlled by a Lambda LS illuminator (Sutter Instru-
ments, Novato, CA). Images were acquired with a cooled digital camera
40 R. Meléndez García et al. / EBioMedicine 7 (2016) 35–49(Cool-SNAP-ES, Roper Scientiﬁc, Tucson, AZ) using the RS image
software (Photometrics; Roper Scientiﬁc). The image ﬁeld was
800 × 600 μm in size (Ramirez et al., 2012). Short movies (180 s total
time, at 40 ms exposure at 4 Hz) were taken in control conditions and
during the wash-in of the pharmacological treatments. To normalize
the change in ﬂuorescence of the treated cultures, their Δ ﬂuorescence
was corrected by subtracting that of one of the untreated conditions.
2.22. Image Analysis
Images were analyzed using Image J (V.1.36, National Institutes of
Health). The cells in a ﬁeld were semiautomatically identiﬁed, and
their mean ﬂuorescence was measured as a function of time. Single-
pixel noise was removed using a 5-pixel ratio mean ﬁlter. Ca2+-
dependent changes in ﬂuorescence (Δ ﬂuorescence) were computed
as (Fi− Fo) / Fo where Fi is ﬂuorescence intensity at any given frame,
and Fo is the resting ﬂuorescence.
2.23. Statistical Analysis
In general, all results were replicated in three or more independent
experiments. The number of replicates (n) in each experiment and
how often it was independently repeated (N) is indicated in each ﬁgure
legend. Serum PRL levels are reported as mean ± S.D. and all others as
mean ± S.E.M.; all data showed normal distribution or equal variance
according to D'Agostino-Pearson omnibus and Levene's tests, respec-
tively. Statistical differences between two groups were determined by
a two-tailed Student's t-test, among three groups with one variable by
one-way ANOVA followed by Bonferroni's post-hoc comparison test,
and among four groups with two variables by two-way ANOVA follow-
ed by Bonferroni's post-hoc comparison test (Sigma Stat 7.0, Systat
Software Inc., San Jose, CA). Differences in means with P b 0.05 were
considered statistically signiﬁcant.
2.24. Gender Analysis
Mice of both genders (ratio almost 1:1 for wild-type: 16 males and
13 females, and prlr−/− mice: 14 males and 17 females) were used.
We did not assess the stage of estrous. Independent analysis for either
sex did not show any signiﬁcant difference in the PRL receptor distribu-
tion or in the assays presented in Fig. 6 (data not shown).
3. Results
3.1. PRL and PRL Receptor are Present in Rodent RPE
PRL receptormRNAwas found in the RPE layer from rat retinal cross
sections by in situ hybridization (Fig. 1a). Immunohistochemistry using
the U5 anti-PRL receptor antibody labels the PRL receptor in whole
mounts of mouse RPE, whereas no speciﬁc signal appeared in prlr−/−
RPE (Fig. 1b).
PRL signaling is triggered by PRL binding to preformed PRL receptor
homodimers (Tallet et al., 2011). Immunohistochemistry was per-
formed on retina sections using RPE-65 isomerase as an RPE marker
(Hamel et al., 1993). We observed immunopositive staining for PRL in
RPE-65-expressing cells (Fig. 1d). PRL colocalized with RPE-65 within
the cytoplasm of RPE cells.
All together, these data suggest that the RPE is a target for autocrine/
paracrine actions of PRL.
3.2. Endogenous PRL is a Trophic Factor for Human RPE cells
To explore the direct effects of the PRL signaling pathway on theRPE,
we ﬁrst used a human RPE cell line, ARPE-19 (Dunn et al., 1996), in
which we found both PRL receptor mRNA (Fig. 2a) and protein
(Fig. 2b). We also observed that PRL was present in the conditionedmedium of ARPE-19 cell cultures (Fig. 2c). We assessed levels of bioac-
tive PRL using the Nb2-cell bioassay and found a PRL concentration of
1.7 ± 2.1 ng/ml in the conditioned medium of ARPE-19 cell cultures
(Fig. 2d). Of note, 10% FBS medium contained 0.031 ± 0.18 ng/mL
(Fig. 2d). Previous studies demonstrated that PRL regulates cell survival,
proliferation, and apoptosis in a variety of cell types (Adan et al., 2013;
Morales, 2011; Yu-Lee, 2002). To assess the direct involvement of en-
dogenous PRL in RPE cell survival, ARPE-19 viability was tested in the
presence of anti-PRL polyclonal antibody (Castilla et al., 2010), normal
rabbit serum or the competitive PRL receptor antagonist Del1-9-
G129R-hPRL (Bernichtein et al., 2003) for 48 h. Both anti-PRL antibody
and the highest dose of Del1-9-G129R-hPRL decreased ARPE-19 cell
survival by 20–30% relative to the control, while pre-immune serum
did not (Fig. 2e). Using 3[H] incorporation, we showed that Del1-9-
G129R-hPRL diminished ARPE-19 cell proliferation by 13 ± 3% and
also prevented the proliferative effect of recombinant human PRL
(hPRL, Fig. 2f).
3.3. PRL Protects and Rescues Human RPE Cells From Hydrogen Peroxide
(H2O2)-induced Damage
The RPE is in a location in the retina where it is in constant contact
with ROS. H2O2 has been used as a direct oxidant to initiate and study
cellular oxidative stress, because it is generated by the RPE during
phagocytosis of the photoreceptor outer segments (Miceli et al.,
1994). Dose-response experiments showed that H2O2 markedly
inhibited ARPE-19 cell survival with an IC50 of 57 μM after a 24-h treat-
ment (Fig. 3a). Using 100 μMH2O2, we showed that this effect involved
both a drastic reduction of cell proliferation (82 ± 6%; Fig. 3b) and a
marked increase in apoptosis (51 ± 12%; Fig. 3c), as determined by
internucleosomal DNA fragmentation measured by ELISA. We next
evaluated whether PRL protected against the effect of a 24-h exposure
to 100 μM H2O2 (Fig. 3d). H2O2 reduced RPE cell survival (Fig. 3e) and
induced apoptosis (Fig. 3f), and these effects were prevented by PRL.
Alone, PRL promoted the survival of ARPE-19 cells, but it did notmodify
their levels of apoptosis. We then investigated restorative properties of
PRL by administering PRL 18 h after H2O2 treatment (Fig. 3g), i.e., when
oxidative damage is evident (Fig. 3h, i). PRL reversed the reduction in
cell survival (Fig. 3h) and the increase in apoptosis (Fig. 3i) induced
by H2O2. Alone, PRL did not modify ARPE-19 cell survival or apoptosis.
3.4. PRL Reduces Intracellular Levels of ROS in Human RPE Cells, Thus
Decreasing the Cytotoxic Effect of SIRT2
Serum levels of PRL were previously shown to positively correlate
with superoxide dismutase (SOD) activity in mammary tissues
(Bolzan et al., 1995), but whether PRL directly favors an antioxidant
environment remains elusive. The antioxidant N-acetyl cysteine
(Kerksick and Willoughby, 2005) prevented the reduction in ARPE-
19 cell survival induced by H2O2 (Fig. 4a), thereby mimicking PRL ac-
tions. Further, PRL reduced the increase in total ROS levels associated
with H2O2 exposure to control levels (Fig. 4b). Alone, PRL decreased
the total levels of ROS. We showed that ARPE-19 cells increased their
antioxidant capacity by 1.8-fold in response to H2O2, and by 3.6-fold
in the presence of PRL and H2O2 (Fig. 4c), but PRL alone did not mod-
ify the antioxidant capacity. The mRNA levels of endogenous antiox-
idant enzymes such as catalase, SOD, and glutathione peroxidase
were assessed by quantitative PCR. Fig. 4d shows that exposure to
H2O2 increased the levels of Mn2+-SOD, Cu2+-SOD, and glutathione
peroxidasemRNA by 45± 1.0%, 30± 0.5%, and 36± 0.5% of controls,
respectively, but did not alter catalase levels. PRL did not modify the
H2O2-mediated increase in Mn2+-SOD, Cu2+/Zn2+-SOD, and gluta-
thione peroxidase levels, nor did PRL change catalase mRNA levels.
PRL by itself did not modify themRNA levels of any of these enzymes.
Additionally, we quantiﬁed reduced GSH levels since N-acetyl cyste-
ine, which mimics PRL actions, is a precursor of glutathione.
Fig. 3. PRL promotes human RPE cell survival. (a) Dose-response curve showing the inhibitory effect of hydrogen peroxide (H2O2) on ARPE-19 survival. Increasing H2O2 doses diminished
ARPE-19 cell survival. (b) Proliferation of ARPE-19 cells was reduced by 82 ± 6% and (c) apoptosis was increased by 51 ± 12% with 100 μMH2O2 present for 24 h. (d) Timeline diagram
depicting the design of the preventive experiments e and f. (e)When applied alone, hPRL promoted ARPE-19 cell survival, while application of hPRL 24 h before the 24-h treatment with
100 μM of H2O2, prevented the H2O2-induced reduction of survival. (f) hPRL prevented the H2O2-mediated increase of apoptosis, while it had no effect alone. (g) Timeline diagram
depicting the design of the restorative experiments h and i. (h, i) When applied during the last 6 h of a 24-h treatment with 100 μM H2O2, hPRL prevented the H2O2-induced reduction
of survival (h) and the H2O2-mediated induction of apoptosis (i), while hPRL alone had no effect. Note that the restorative scheme of hPRL administration showed results similar to
those with the preventive scheme of administration. Incorporation of [3H]thymidine was normalized to the untreated condition. (n= 12; N= 3 independent replicates). All bar plots,
mean plus S.E.M.; P values: ANOVA and Bonferroni post-hoc test. Of note, the control condition corresponds to cells that were pre-treated with 1% FBS medium during 12 h followed
by a 24-h (b, c, h, and i) or 48-h (e, f) period in the same medium.
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not only prevented but also reversed by PRL (Fig. 4e). Alone, PRL
did not modify GSH levels. These results indicate that PRL limits the
impact of oxidative stress in human RPE.
H2O2 has been found to induce expression of the deacetylase SIRT2
in prostate epithelial cells (Nie et al., 2014), and PRL receptor dimeriza-
tion and subsequent signaling are inhibited by SIRT2-mediateddeacetylation (Ma et al., 2010). SIRT2 is expressed in the retina (Geng
et al., 2011), and SIRT2 inhibitors, including AGK2, can decrease cell
death in various models of neurodegeneration (Villalba and Alcain,
2012). qPCR analysis of the SIRT2 gene showed that PRL prevented the
2.4-fold increase in SIRT2 mRNA levels induced by H2O2 compared
with levels in untreated conditions (Fig. 4f). Alone, PRL did not modify
the ARPE-19 cell content of SIRT2 transcript. We also found that
Fig. 4. PRL boosts antioxidant defenses and prevents the oxidant-induced SIRT2 effects on human RPE cells. (a) Effect of the antioxidant N-acetyl cysteine (NAC, 10 mM) on ARPE-19
survival. NAC was applied 24 h before of the 24-h H2O2 insult. (b) ROS production and (c) antioxidant capacity in control condition, following H2O2 (100 μM) treatment for 24 h, and
in the presence of hPRL (100 pM) for 48 h alone or 24 h before the 24-h treatment with H2O2. The same treatment scheme was used in d, e, and f. (d) qRT-PCR analyses of mRNAs for
catalase, Mn2+-dependent SOD (Mn2+-SOD), Cu2+/Zn2+-dependent SOD (Cu2+/Zn2+-SOD), and glutathione peroxidase in ARPE-19 cell lysates. qRT-PCR data are normalized to TBP
levels (n= 3; N= 3 independent replicates). (e) Reduced glutathione (GSH) levels in lysates from ARPE-19 cells. (f) qRT-PCR analyses of SIRT2 mRNA in ARPE-19 cells. qRT-PCR data
were normalized to TBP levels (n= 3–6; N= 3 independent replicates). (g) Effect of the SIRT2 inhibitor AGK2 on ARPE-19 survival. AGK2 (10 μM) was applied 24 h before of the 24-
h H2O2 insult. (h) Effect of hPRL on ARPE-19 survival challenged by the SIRT2 activator piceatannol. When hPRL (100 pM) was applied 24 h before of the 24-h piceatannol (10 μM)
challenge, it prevented piceatannol-induced reduction of survival. ROS accumulation values were normalized to the untreated conditions. Excluding (d), n = 12; N = 3 independent
replicates. All bar plots, mean plus S.E.M.; P values: ANOVA and Bonferroni post-hoc test. Of note, the control condition corresponds to cells that were pre-treated with 1% FBS medium
during 12 h followed by a 48-h period in the same medium.
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duced by H2O2 (Fig. 4g), as did PRL. Alone, AGK2 did not modify ARPE-
19 cell survival. To test the possibility that PRL preserves the integrity of
human RPE by inhibiting SIRT2, we used piceatannol, an analog ofresveratrol (Piotrowska et al., 2012) known to stimulate SIRT2
(Howitz et al., 2003). Like H2O2, piceatannol (10 μM, (Piotrowska
et al., 2012)) diminished ARPE-19 cell survival, an effect that was
blocked by PRL (Fig. 4h).
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induced SIRT2-dependent Increase in Intracellular Ca2+ That is Mediated
by TRPM2 Channels
Previous studies demonstrated that SIRT2 activity produces 2′O-ace-
tyl-ADP-ribose (Zheng, 2013), a metabolite that binds the cytosolic, C-
terminus of TRPM2 channels, leading to an increase in intracellular
Ca2+ levels that correlates with cell death (Faouzi and Penner, 2014).
While TRPM2 mRNA has been reported in the retina (Gilliam and
Wensel, 2011), the presence of these channels in RPE is unknown. We
found that ARPE-19 cells expressed TRPM2 mRNA (Fig. 5a) and protein
(Fig. 5b). siRNA against TRPM2 decreased protein levels of the channel
in ARPE-19 cells (Fig. 5b). Using the Ca2+ indicator ﬂuo-8, we observed
that exposure to H2O2 elicited a sustained increase in intracellular Ca2+
levels that was prevented by siRNA against TRPM2 or by a 15-min pre-
treatment with PRL (Fig. 5c). Scrambled siRNA or PRL alone did not
modify intracellular Ca2+ levels. We observed that SIRT2 activation by
piceatannol caused an increase in intracellular Ca2+ levels that had sim-
ilar amplitude and kinetics to the one evoked by H2O2, and that was
inhibited by siRNA against TRPM2 or PRL (Fig. 5d). We also found that
the H2O2-mediated increase in intracellular Ca2+ levels was prevented
by a 15-min pretreatment with AGK2 (Fig. 5e). We then evaluated
whether the inhibition of TRPM2 channels preserved human RPE sur-
vival under oxidant conditions. We found that siRNA against TRPM2
minimized the reduction in ARPE-19 cell survival induced by H2O2
(Fig. 5f). Scrambled siRNA did notmodify the levels of ARPE-19 survival
in the presence of H2O2.
3.6. RPEDegeneration is EnhancedDuring Advancing Age and inMice Lack-
ing PRL Receptor
In order to examine the in vivo relevance of our ﬁndings, whole
mounts of RPE from 5- and 14-month-old prlr−/−mice were evaluated
by the TUNEL assay. In young mice, there was positive TUNEL signal in
the RPE (Fig. 6a), indicating that PRL is required for the survival of RPE
under normal conditions. Apparentmorphological alterations including
an increased number of cells that have more than two nuclei were also
detected in the 5-month-old prlr−/−mice. Consistent with RPE degen-
eration being a feature of age-related retinal degeneration (Nag and
Wadhwa, 2012), 14-month-old prlr+/+ mice showed more TUNEL sig-
nal in RPE, compared to that in 5-month-old prlr+/+mice (Fig. 6a). Pos-
itive TUNEL signal was also present in the RPE from prlr−/−mice with
advancing age (Fig. 6a). The higher levels of apoptosis in 5- and 14-
month-old prlr−/− RPE were statistically signiﬁcant after quantifying
the TUNEL signal (Fig. 6b). Also, the number of RPE cells decreased in
5-month-old prlr−/− mice compared with age-matched wild-type
counterparts, and they had more nuclei (Fig. 6b). Evaluation of the sur-
face and perimeter of individual RPE cells showed hypertrophy of RPE
cells from prlr−/−mice compared with those from wild-type counter-
parts: RPE cell surface and perimeter were higher in 5- and 14-
month-old prlr−/−mice compared with age-matched wild-type mice,
respectively (Fig. 6c). However, the surface and perimeter of RPE cells
from 5-month-old wild-type and prlr−/− mice were similar to those
of 14-month-old wild-type and prlr−/− mice, respectively (Fig. 6c).
These data suggest that PRL helps to maintain the morphology of RPE,
and that this effect was independent of age. We then analyzed the pro-
duction of superoxide anion in whole mounts of RPE. Fig. 6d shows rep-
resentative images of whole mounts of RPE stained with the oxidative
ﬂuorescent dye dihydroethidium (DHE), and quantiﬁcation using the
mean pixel ﬂuorescence intensity ratio of DHE/DAPI is provided in
Fig. 6e. The RPE from young prlr−/− mice produced more superoxide
anion than RPE fromage-matchedwild-type counterparts.While super-
oxide anion levels were higher in the RPE from 14-month old prlr+/+
mice than those of young mice, they were similar in the RPE of 14-
month old prlr+/+ and prlr−/− mice. We then explored whether re-
duced overall synthesis of antioxidant enzymes correlates withincreased oxidative stress in prlr−/− retinas. Catalase mRNA levels
were reduced in young prlr−/− retinas by 55 ± 3% compared with
values from age-matched prlr+/+ retinas (Fig. 6f). Consistent with oxi-
dative stress being a hallmark of aging retina (Ardeljan and Chan,
2013), catalase expression was reduced equally in retinas of prlr+/+
and prlr−/−micewith advancing age. Lack of PRL receptor or advancing
age per sewas accompanied by a 2.4- or 3.5-fold increased synthesis of
SIRT2 in the retina, respectively, compared to young wild-type retinas
(Fig. 6f). The SIRT2 mRNA levels were comparable in the retinas of 14-
month old prlr+/+ and prlr−/−mice. Further, we measured negligible
levels of PRL receptor and PRL mRNA in the retina of 14-month old
mice (Fig. 6g), supporting the notion that under the oxidative condi-
tions accompanying aging, increased levels of SIRT2 are associated
with reduced PRL signaling and RPE cell death.
4. Discussion
The multigenic and complex etiology of age-related retinal diseases
in humans is responsible for the relative paucity of effective compounds
for their early prevention and treatment. Given that the relationship be-
tween the RPE and photoreceptors is crucial to sight (Sparrow et al.,
2010), identifying pathways necessary for RPE function is essential to
uncover therapies for blindness. The present study identiﬁes the PRL
signalingpathway in the adult RPE anddemonstrates that it is necessary
for RPE survival. PRL receptor antagonism or deﬁciency increases RPE
apoptosis both in vitro and in vivo and conversely, PRL receptor stimula-
tion promotes the resistance of RPE cells to oxidative stress. One of the
mechanisms by which PRL signaling mediates its protective effects in
the RPE is through antioxidant actions that lead to decreased SIRT2
expression and TRPM2 inhibition. This study strengthens the signiﬁ-
cance of the PRL pathway beyond its classical roles in lactation since
no sex-based difference in PRL-mediated RPE effects were observed in
our experimental conditions. Nevertheless, it is possible that sex-
based differences do occur under physiological conditions such as preg-
nancy and lactation given that the amplitude of the ERG B-wave is
higher in pregnant women (De Luca Brunori et al., 1985).
Although the role of PRL in NO signaling has been widely studied
(Duckles and Miller, 2010), the direct action of PRL on ROS has not
been shown previously. In response to oxidative stress, we found that
PRL reduced the levels of ROS and promoted the antioxidant capacity
of ARPE-19 cells by increasing GSH levels in the RPE. More importantly,
prlr−/− RPE exhibited increased staining for the superoxide indicator
DHE, and mRNA levels of catalase were reduced in prlr−/− retinas orig-
inating fromyoungor agingmice. These data are consistentwith the ob-
servations that reduced levels of circulating PRL associate with
increased plasma oxidant status in rats (Yuksel et al., 2015). However,
blockage of PRL secretion was also reported to associate with enhanced
antioxidant defense (Ricke-Hoch et al., 2014) and more particularly,
with increased activity of antioxidant enzymes like catalase (Brown-
Borg et al., 1999). The reasons for this inconsistency are unknown but
may relate to the ﬁnely tuned balance between ROS levels and antioxi-
dant defenses. It is clear that if ROS levels are high enough to overwhelm
the antioxidant defenses or if the antioxidant protective mechanisms
are compromised, then the resulting oxidative stress may lead to aber-
rant cell signaling throughoxidativemodiﬁcation of redox-sensitive sig-
naling proteins (Finkel and Holbrook, 2000). Whether PRL or its
receptor are susceptible to oxidative modiﬁcations remains to be inves-
tigated. The present study also shows that advancing age associates
with decreased expression of PRL andPRL receptor in the retina.Wheth-
er the down-regulation of PRL and its receptor occurs speciﬁcally in the
RPE was not determined. Nonetheless, increased oxidative stress and
phenotypic changes in the RPE have been reported (Zhao et al., 2011).
Along this line, the best-validated therapies remain oral antioxidant
supplements based on those investigated in the Age-Related Eye Dis-
ease Study (AREDS) and the recently completed AREDS 2 (Broadhead
et al., 2015; Wei et al., 2016). Here, we show that N-acetyl cysteine
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ty of ARPE-19 cells under oxidative stress. Moreover, we found that PRL
per se reduced intracellular levels of ROSwithout modifying the antiox-
idant capacity of ARPE-19 cells. The mechanism underlying this effect
has not been explored, but the expression of PRL receptors positivelyFig. 5. PRLmaintains human RPE cell survival by inhibiting the oxidant-induced SIRT2-depende
blotting of TRPM2 in ARPE-19 cell lysates. (a) TBP was used as a positive control. bp, DNA ladde
(b) ARPE-19 cells were untreated (Ctl), subjected to lipofectamin alone (Lipo.) or transfected
reduced TRPM2 expression as observed by immunoblotting using an anti-TRPM2 antibody
served as loading control. Extracts from three independent ARPE-19 cell cultures in each co
measured by the change in ﬂuo-8 ﬂuorescence (Δ ﬂuorescence) in ARPE19 cells exposed to (c
TRPM2 or PRL was applied (hPRL, 100 pmol/l, 15-min pretreatment). Scramble sequence (siRN
piceatannol began at time = 0 s (n= 170–190 cells; N= 3 independent replicates). (e) Ca2+
AGK2 (10 μM) combined or not with H2O2 (100 μM) (n = 160–190 cells; N = 3 independe
H2O2 insult (100 μM) by MTT assay. ARPE-19 cells were untreated (Ctl), treated with lipofec
(Scr.) 24 h prior initiating the MTT assay. In (c–e), signals were normalized by subtracting the
P values: ANOVA and Bonferroni post-hoc test.correlates with mRNA abundance for uncoupling proteins UCP1
(Bispham et al., 2005) and UCP2 (Pearce et al., 2003), which are mito-
chondrial anion carrier proteins that are involved in minimizing ROS
emission from the electron transport chain (Mailloux and Harper,
2011).nt induction of TRPM2-mediated intracellular Ca2+ increase. (a) RT-PCR and (b)Western-
r. RT-PCR was performed in RNA extracted from three independent cell cultures (N= 3).
with siRNA against TRPM2 (siRNA) or scramble sequence (Scr.). TRPM2 siRNA efﬁciently
that labeled a protein at the expected molecular weight for TRPM2 (171 kDa). β-Actin
ndition were analyzed (N = 3). (c, d) Measurement of the change in intracellular Ca2+
) H2O2 (100 μM) or (d) piceatannol (10 μM) while TRPM2 was blocked by siRNA against
A ctl) was used as a negative control for siRNA against TRPM2. Treatments with H2O2 or
-dependent ﬂuorescence change in ARPE19 cells 180 s after application of SIRT2 inhibitor
nt replicates). (f) Effect of TRPM2 inhibition on survival of ARPE-19 subjected to a 24-h
tamin alone (Lipo.) or transfected with siRNA against TRPM2 or the scramble sequence
Fluo-8 Δ ﬂuorescence to the one in untreated conditions. All bar plots, mean plus S.E.M.;
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here we show that H2O2 attenuated ARPE-19 cell survival by inhibiting
their proliferation and stimulating their apoptosis, as evaluated by re-
duced 3[H] incorporation and increased DNA fragmentation, respective-
ly. Administering PRL before or after injury opposed the H2O2 cytotoxic
and proapoptotic effect on ARPE-19 cells. The molecular mechanisms
underlying this effect were not analyzed, but PRL is a well-known
anti-apoptotic factor. It activates STAT3 (Adan et al., 2013), which sig-
nals to inhibit apoptosis by inducing Bcl-2 (Suemoto et al., 2007) and
decreasing p53 (Adan et al., 2013) transcription. Reduced Bcl-2 contrib-
utes to RPE death by apoptosis, while pharmacologic treatments to
block p53 expression can protect RPE cells from apoptosis
(Bhattacharya et al., 2012).
The fact that PRL counteracts the proapoptotic effect of H2O2 ar-
gues in favor of its pro-survival effect on RPE under oxidative stress.
Conversely, lack of PRL signaling should result in RPE apoptosis
under pro-oxidant conditions. To investigate this concept, we stud-
ied the RPE in situ and chose advancing age as a model of RPE degen-
eration. Apoptosis occurred, but we did not observe any signiﬁcant
hypertrophy of RPE cells as others did in human tissue (Nag and
Wadhwa, 2012). Notably, we showed that the levels of apoptosis
were greater in the RPE of prlr−/− mice with advancing age than in
the RPE of aged-matched wild-type mice or young prlr−/− mice.
These data demonstrate the trophic effect of PRL on RPE in vivo.
The antiapoptotic effect of PRL under challenging conditions was
clearly established earlier (Marano and Ben-Jonathan, 2014). In par-
ticular, PRL protects beta cells in vitro from H2O2 (Yamamoto et al.,
2010) and limits photoreceptor apoptosis in a phototoxicity model
of retinal degeneration (Arnold et al., 2014).
PRL is essential for adult RPE survival. Targeted disruption of the PRL
receptor gene causes apoptosis and reduces the number of RPE cells in
this tissue, indicative of a defect in RPE survival, and also hypertrophy,
which is known to lead to gradual atrophy (Nag and Wadhwa, 2012).
Further supporting this notion is the fact that increased apoptosis and
hypertrophy are observed in prlr−/− RPE independently of advancing
age. Also, we show that immunoneutralization of PRL as well as a pure
PRL receptor antagonist (Bernichtein et al., 2003) reduce ARPE-19 cell
survival andproliferation, indicating that endogenous PRL is amajormi-
togenic factor for these cells.
A key issue is whether RPE is responding to local or circulating PRL,
or both. Radioactive PRL injected intracardially is incorporated into ocu-
lar tissues (ciliary body, choroid, and retina) (O'Steen and Sundberg,
1982). The ciliary body is responsible for the active transport of plasma
proteins to intraocular ﬂuids (Mestriner and Haddad, 1997), and we
demonstrated that the PRL receptor is localized in this structure
(Arnold et al., 2010). To examine if the PRL receptor in the ciliary body
could mediate uptake of circulating PRL, we analyzed retinal PRL in
prlr−/−mice, which are known to be hyperprolactinemic (Schuff et al.,
2002). The mice displayed 700-fold higher levels of circulating PRL
(Arnold et al., 2010), but the levels of retinal PRL were similar to those
of their wild-type littermates (Supplemental Fig. 5). A similar mecha-
nism can also take place directly in the outer component of the blood-
retina barrier, although this alternative warrants further investigation.
If the exact contribution of local versus circulating PRL at RPE site
needs further investigation, it is worth mentioning that both the
estimated concentration of PRL in the conditioned media of ARPE-19
cultures and the dose of exogenously administered PRL are in the phys-
iological range. PRL was previously shown to be necessary for cell
survival in the absence of a challenging context in adult mice
(Grosdemouge et al., 2003). Here, we demonstrate that a hormone is
necessary for adult RPE survival. Such a conclusion had been reached
previously only for antioxidant enzymes (Justilien et al., 2007) or tran-
scription factors (Zhong et al., 2012).
A number of studies have demonstrated that oxidative injury in RPE
cultures can be mitigated by compounds that exhibit antioxidant prop-
erties, including resveratrol (Chan et al., 2015). In contrast, we observedthat piceatannol, a naturally occurring hydroxylated analog of resvera-
trol, promotes a sustained increase of intracellular Ca2+ that can cause
apoptosis (Berridge et al., 2000) and reduces the survival of ARPE-19
cells. These data are consistent with a study showing that resveratrol
and some of its analogs exert cytotoxic effects on normal
nontransformed cells (She et al., 2003). Additionally, piceatannol has
been previously associatedwith opposite effects on cell growth depend-
ing on its concentration, i.e., low doses (nM range) induce cell growth
whereas high doses (μM range) attenuate cell growth (Vo et al., 2010).
Resveratrol and its analogs are substrate-speciﬁc activators of yeast
and human sirtuins (Villalba and Alcain, 2012). Among the sevenmem-
bers of the mammalian sirtuin family, SIRT2 has been detected in adult
retina (Geng et al., 2011), and disruption of its signaling has been pro-
posed as an endogenous therapeutic target to preserve the integrity of
aging cells against exogenous stressors such as ROS (Cheng et al.,
2003). SIRT2 inhibition by AGK2 results in decreased ROS levels (Nie
et al., 2014), which coincides with PRL decreasing intracellular levels
of ROS in ARPE-19 cells. Consistent with studies showing that oxidative
stress up-regulates SIRT2 (Nie et al., 2014), we found that both H2O2 ex-
posure and advancing age cause the elevation of SIRT2 mRNA levels in
ARPE-19 cells and mouse retinas, respectively. The fact that AGK2 de-
creases H2O2-induced apoptosis in ARPE-19 cells indicates that in
these cells, SIRT2mediates oxidative stress-induced apoptosis, as previ-
ously reported (Nie et al., 2014). Also, we show that PRL prevents the in-
duction of SIRT2 expression under pro-oxidant conditions in ARPE-19
cells and that SIRT2 expression tends to be elevated in retinas from
prlr−/−mice with advancing age compared to age-matched wild-type
animals. Most conspicuously, SIRT2 expression was elevated in prlr−/−
retinas from young mice. Considering that SIRT2 inactivates the PRL re-
ceptor through its deacetylation (Ma et al., 2010), our data suggest that
a negative feed-back loop between SIRT2 and PRL signaling may exist.
Together with the fact that PRL prevents the reduction in ARPE-19 cell
survival induced by piceatannol, these data lead us to propose that
PRL, by reducing ROS levels, maintains SIRT2 at levels that contribute
to RPE survival. Conversely, under oxidizing conditions, increased levels
of SIRT2 blunt PRL signaling, leading to RPE cell death. The possibility
that PRL may directly regulate SIRT2 needs further studies.
Although PRL signaling, SIRT2, and TRPM2 channels are currently
viewed as being independent, we suggest that these pathways are
more intricately connected than previously appreciated. We report
here that TRPM2 is expressed in ARPE-19 cells. This result complements
a previous study showing that all TRP channel genes are expressed in
the retina (GilliamandWensel, 2011).We also show that H2O2 activates
TRPM2 leading to Ca2+ inﬂux in a SIRT2-dependentmanner since AGK2
blocks the H2O2-induced Ca2+ increase in ARPE-19 cells. In parallel, si-
lencing TRPM2 inhibited the piceatannol-induced increase in intracellu-
lar Ca2+, suggesting that SIRT2 increases intracellular Ca2+ by activating
TRPM2. Thus, we assume that TRPM2 channels are activated by H2O2 in
a SIRT2-dependent manner in ARPE-19 cells. Undoubtedly, the TRPM2-
mediated Ca2+ rise is a dominant source of the Ca2+ required to reduce
ARPE-19 cell viability under pro-oxidant conditions (Fig. 5f). Our obser-
vations are consistent with previous studies demonstrating that the
TRPM2 Ca2+ current links oxidative stress-induced SIRT2 activation to
oxidative stress-induced cell death (Faouzi and Penner, 2014).
The novelty here consists in demonstrating that PRL inhibits the
oxidant-induced SIRT2-dependent activation of TRPM2 channels. PRL
alone does notmodify Ca2+ levels, and there is no evidence that PRL ac-
tivates TRPM2. Instead, PRL seems to block TRPM2 once this latter is ac-
tivated.We emphasize that this effect cannot be attributed to the ability
of PRL to reduce SIRT2 transcription, because the time course of the two
events is different (seconds/minutes versus 24 h). Reduced levels of in-
tracellular ROS may explain the short-term effect of PRL on TRPM2 as
well as the restorative effect of PRL at 6 h, though further studies
using different techniques and dyes are required to address this issue.
Interestingly, TRPM2 current density was shown to increase in cultured
pyramidal neurons over time in vitro. This increase in current density
Fig. 6. RPE death in wild-type and PRL receptor-null mouse. (a) Representative stack image of TUNEL staining (green) in RPE ﬂat-mounts of 5-month- and 14-month-old wild-type (prlr+/+)
and PRL receptor-null (prlr−/−) mice in x-y axis. Rhodamine-phalloidin labeled F-actin (red), and DAPI labeled the nuclei (blue). Arrow indicates positive TUNEL stain and asterisks indicate
morphological alterations. Corresponding separate images in x-y and z-axis projection were presented in Supplemental Fig. 4. Six sections per ﬂat mount in three mice were observed.
(b) Quantiﬁcation of TUNEL-positive apoptosis signal in whole mounts of RPE (left upper panel; n = 4–11; N = 3 independent replicates). Quantiﬁcation of cell number in RPE ﬂat mounts
from wild-type and prlr−/−mice. Data are presented as raw numbers (n = 4 sections of 200–200 μm per group from 6 ﬂat mounts from 3 mice were analyzed). Note that no cell had 3, 4
or 6 nuclei in RPE ﬂat mounts. (c) Averaged surface (right upper panel) and perimeter (right lower panel) of individual RPE cells from 5-month- and 14-month-old prlr+/+ and prlr−/−
mice. In (a–c), the 5-month-old prlr+/+ and prlr−/−mouse group was composed of four males and three females and of three males and four females, respectively, while the 14-month-old
prlr+/+ and prlr−/−mouse group was composed of four males and two females and of three males and ﬁve females, respectively. (d) Representative images of superoxide anion production
stained with DHE in RPE ﬂat mounts of 5-month-old prlr+/+ and prlr−/−mice, and of 14-month-old prlr+/+ mice. (e) Quantiﬁcation of ﬂuorescence intensity as mean number of pixels
positive for DHE staining normalized to the mean number of pixels positive for DAPI staining (not shown). Six sections per ﬂat mount in three mice per group were observed. The 5-month-
old prlr+/+ and prlr−/−mouse group was composed of one male and two females, respectively, while the 14-month-old prlr+/+ and prlr−/−mouse group was composed of two males and
one female. (f) qRT-PCR analyses of catalase and SIRT2 mRNA in retina extracts of 5-month- and 14-month-old prlr+/+ and prlr−/−mice. (g) qRT-PCR analyses of PRL receptor and PRL
mRNA from retina extracts of 5-month- and 14-month-old prlr+/+ and prlr−/−mice. All qRT-PCR data were normalized to TBP levels (n= 6 per genotype, 3 males and 3 females each;
N= 3 independent replicates). Magniﬁcation bars as indicated. All bar plots, mean plus S.E.M. except in (b); P values: ANOVA and Bonferroni post-hoc test.
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Fig. 7. Schematic depiction of the antiapoptotic conditions including the PRL signaling pathway in young RPE versus the proapoptotic conditions in aging RPE. Young RPE cells express PRL
and its receptor (PRLR) that (1) signal for the synthesis of reduced glutathione (GSH) that transforms two molecules of hydrogen peroxide (H2O2) into water and (2) induces the
transcription of catalase, which also processes H2O2 into water; both of these processes limit ROS levels. This antioxidant pathway is more prominent than the pro-oxidant pathway
comprised by the TRPM2-mediated intracellular Ca2+ rise induced by the metabolite 2′O-acetyl-ADP-ribose (O-Ac-ADPR) that results from the deacetylation (removal of Ac group) of
various substrates by SIRT2. The viability of RPE is therefore not jeopardized. In contrast, in aged RPE cells, the PRL signaling pathway is blunted. Therefore, the pro-oxidant pathway
predominates over the antioxidant one. High levels of ROS, illustrated by increased H2O2, promote the up-regulation of SIRT2 which, in turn, activates TRPM2 by producing O-Ac-
ADPR. The subsequent sustained rise in intracellular Ca2+ levels can depolarize mitochondria (Berridge et al., 2000), which causes apoptosis. RPE from PRLR null (−/−) mice
emphasizes these features.
47R. Meléndez García et al. / EBioMedicine 7 (2016) 35–49was prevented by treatment with N-acetyl cysteine and conversely, de-
pletion of GSH augmented TRPM2 currents (Lee et al., 2010).
Importantly, PRL is proteolytically cleaved in the retina to yield
vasoinhibins (Clapp et al., 2006), a family of peptides that act on both
endothelial and RPE cells to prevent the hypervasopermeability associ-
ated with diabetes (Arredondo Zamarripa et al., 2014). Vasoinhibins
exert actions through a mechanism independent of the PRL receptor
(Bajou et al., 2014). The existence of such mechanisms therefore
makes the prlr−/−mouse a complex model since exaggerated signaling
through non-PRL receptor pathways may be expected. However, we
previously demonstrated that in spite of being hyperprolactinemic,
prlr−/−mice do not show increased levels of vasoinhibins in their ret-
inas (Arnold et al., 2010).
Our general view is that antiapoptotic mechanisms including the
PRL signaling pathway degradewith advancing age so that RPE cells be-
come vulnerable to normal proapoptotic stressors such as ROS, SIRT2,
and elevated intracellular Ca2+ levels, creating a tipping point beyond
which retinal homeostasis is lost (Fig. 7), leading to visual dysfunction
as we previously reported (Arnold et al., 2014). Concomitantly with
RPE damage, rhodopsin mRNA levels and cone and rod photoreception
are compromised in the prlr−/−mice (Arnold et al., 2014). A similar de-
gree of alterations in electroretinogram parameters was previously
shown to associate with reduced visual acuity in various animal models
(Bonnet Wersinger et al., 2014; Deming et al., 2015; Hilgen et al., 2012;
Kohl et al., 2015).
Most studies devoted to detecting changes in plasma levels of PRL
during aging in humans have been carried out in males, usually with
age-range subject selection, which results in considerable variability
and conﬂicting results. In most studies, healthy aging subjects showed
no change in circulating levels of pituitary PRL (Rossmanith et al.,
1992; Schiavi et al., 1992; Yamaji et al., 1976), while some showed a de-
crease (Saucedo et al., 2000; van Coevorden et al., 1991). From a clinical
point of view, one may consider the option of increasing levels of sys-
temic PRL during advancing age in order to protect the RPE. However,the potential undesirable effects of induced hyperprolactinemia prompt
us to propose instead that targeting SIRT2 or TRPM2 channels with in-
hibitors may improve RPE function in conditions that induce oxidative
stress in the RPE. Therapeutic interventionsmay also beneﬁt from iden-
tifying the signal transduction pathways that link PRL receptor stimula-
tion to antioxidant actions. STAT3 appears to be a main candidate since
signaling through the PRL receptor canonically involves JAK2/STAT3 ac-
tivation (Bole-Feysot et al., 1998), and neuronal oxidative stress associ-
ates with reduced JAK2/STAT signaling (Kaur et al., 2005; Monroe and
Halvorsen, 2006a), an effect that can be counteracted by anti-oxidant
molecules including GSH and NAC (Monroe and Halvorsen, 2006b).
In particular, knockdown of STAT3 has been recently shown to abolish
the protective effects of innate immune system activation in the retina
during oxidative stress (Patel and Hackam, 2014), and PRL is a well-
known modulator of this system (Díaz et al., 2013).
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